Agios Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 03/28/2024

Stock Rating
9
Price Target
$43.50
Consensus
Outperform
Upside
41.23%
Analysts
4
Stock Rating
9
Upside
41.23%
Analysts
4
Price Target
$43.50

Agios Pharmaceuticals Stock Forecast and Price Target

According to four esteemed experts, the average price target for Agios Pharmaceuticals to reach this year is $43.50, with a potential upside of approximately 41.23%. This prediction is based on a high estimate of $49.00 and a low estimate of $29.00. If you're not interested in AGIO stock, you may be interested in its competitors.

$43.50

41.23% Upside

Outperform
Outperform

Agios Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Agios Pharmaceuticals's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $33.41, which would mean an increase of 100.00%. Over the next seven years, experts predict that Agios Pharmaceuticals's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$33.41
2025 Fair Value Forecast
$37.15
2026 Fair Value Forecast
$41.31
2027 Fair Value Forecast
$45.93
2028 Fair Value Forecast
$51.07
2029 Fair Value Forecast
$56.79
2030 Fair Value Forecast
$63.14
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABBV Stock Forecast AbbVie Outperform 9
$179.63 Buy/Sell $178.42 0.21%
AMGN Stock Forecast Amgen Outperform 4
$275.36 Buy/Sell $303.65 14.40%
GILD Stock Forecast Gilead Sciences Inc Outperform 11
$75.32 Buy/Sell $87.82 10.20%
ALXN Stock Forecast Alexion Pharmaceuticals - 0
$182.50 Buy/Sell $177.38 -100.00%
BIIB Stock Forecast Biogen Outperform 10
$230.07 Buy/Sell $299.62 29.09%

Agios Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

In the last year, Agios Pharmaceuticals's Revenue has grown by 88.34%, rising from $14.24M to $26.82M. For next year, analysts predict Revenue of $51.58M, which would mean an increase of 92.32%. Over the next seven years, experts predict that Agios Pharmaceuticals's Revenue will grow at a rate of 4595.64%.

2024 Rev Forecast
$0.05B
2025 Rev Forecast
$0.12B
2026 Rev Forecast
$0.24B
2027 Rev Forecast
$0.47B
2028 Rev Forecast
$0.62B
2029 Rev Forecast
$0.90B
2030 Rev Forecast
$1.26B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMRN Stock Forecast BioMarin Pharmaceutical Outperform 10
$86.00 Buy/Sell $111.56 26.40%
INCY Stock Forecast Incyte Outperform 9
$60.79 Buy/Sell $77.05 26.99%
ARNA Stock Forecast Arena Pharmaceuticals - 6
$99.99 Buy/Sell $100.00 -100.00%

Agios Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BPMC Stock Forecast Blueprint Medicines Outperform 6
$89.47 Buy/Sell $85.71 11.77%
IOVA Stock Forecast Iovance Biotherapeutics Buy 4
$15.10 Buy/Sell $20.42 68.87%
ACAD Stock Forecast ACADIA Pharmaceuticals Outperform 6
$24.13 Buy/Sell $33.78 32.62%

Agios Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$-306050000.00
2025 FCF Forecast
$-270350000.00
2026 FCF Forecast
$-181600000.00
2027 FCF Forecast
$0.04B
2028 FCF Forecast
$0.31B
2029 FCF Forecast
$0.60B
2030 FCF Forecast
$0.79B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
FOLD Stock Forecast Amicus Therapeutics Outperform 7
$12.13 Buy/Sell $17.90 64.88%
CCXI Stock Forecast ChemoCentryx - 8
$51.99 Buy/Sell $52.00 -100.00%
CBAY Stock Forecast CymaBay Therapeutics Hold 8
$32.44 Buy/Sell $27.73 0.18%

Agios Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

Agios Pharmaceuticals's EBITDA has seen impressive growth In the last three years, rising from $-326.13M to $-384.86M – a growth of 18.01%. In the following year, 3 experts forecast that Agios Pharmaceuticals's EBITDA will decrease by 13.25%, to $-333.87M. For the next seven years, the forecast is for EBITDA to grow by 19.67%.

2024 EBITDA Forecast
$-333870000.00
2025 EBITDA Forecast
$-506810000.00
2026 EBITDA Forecast
$-481560000.00
2027 EBITDA Forecast
$-459713228.00
2028 EBITDA Forecast
$-422736960.69
2029 EBITDA Forecast
$-449143929.51
2030 EBITDA Forecast
$-460552185.32
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ARWR Stock Forecast Arrowhead Pharmaceuticals Outperform 7
$29.40 Buy/Sell $52.00 87.07%
VKTX Stock Forecast Viking Therapeutics Buy 5
$63.44 Buy/Sell $34.00 73.39%
DRNA Stock Forecast Dicerna Pharmaceuticals - 7
$38.01 Buy/Sell $35.06 -100.00%

Agios Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Agios Pharmaceuticals's EBIT has grown by 16.54%, rising from $-335.92M to $-391.49M. 7 analysts predict Agios Pharmaceuticals's EBIT will decrease by 8.16% in the next year, reaching $-359.53M. By 2030, professionals predict that Agios Pharmaceuticals's EBIT will decrease by 203.94%, to $406.92M.

2024 EBIT Forecast
$-359530000.00
2025 EBIT Forecast
$-377540000.00
2026 EBIT Forecast
$-243800000.00
2027 EBIT Forecast
$-34380000.00
2028 EBIT Forecast
$0.11B
2029 EBIT Forecast
$0.17B
2030 EBIT Forecast
$0.41B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CLDX Stock Forecast Celldex Therapeutics Buy 11
$46.54 Buy/Sell $63.29 65.45%
VCEL Stock Forecast Vericel Buy 8
$44.59 Buy/Sell $42.58 18.86%
ARDX Stock Forecast Ardelyx Buy 11
$8.49 Buy/Sell $9.94 56.07%

Agios Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Agios Pharmaceuticals's EPS has grown by 100.00%, rising from $-4.74 to $0.00. For next year, analysts predict EPS of $-5.07, which would mean an increase of 100.00%. Over the next seven years, experts predict that Agios Pharmaceuticals's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$-5.07
2025 EPS Forecast
$-5.85
2026 EPS Forecast
$-3.52
2027 EPS Forecast
$-0.12
2028 EPS Forecast
$2.01
2029 EPS Forecast
$2.69
2030 EPS Forecast
$5.39
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DVAX Stock Forecast Dynavax Technologies Outperform 11
$12.97 Buy/Sell $25.00 88.90%
XNCR Stock Forecast Xencor Outperform 6
$23.13 Buy/Sell $37.91 47.00%
SAGE Stock Forecast Sage Therapeutics Hold 6
$21.18 Buy/Sell $25.28 18.04%